Moisés
Rodríguez Mañero
2026
-
Comparative pharmacovigilance analysis of suicidality-related adverse events among GLP-1 and non-GLP-1 anti-obesity drugs in the FDA Adverse Event Reporting System
International Journal of Clinical Pharmacy
-
External validation of atrial fibrillation risk scores in heart failure under continuous device surveillance
Heart Rhythm
-
Left ventricular ejection fraction determines the pattern of left atrial remodeling in patients with heart failure without atrial fibrillation
Clinical Research in Cardiology
2025
-
Carvedilol versus flecainide treatment in idiopathic ventricular extrasystoles and tachycardias (CARFLECT IV) trial: Rationale and design
Revista Portuguesa de Cardiologia, Vol. 44, Núm. 12, pp. 709-715
-
Effects of GLP-1 agonists on 10-year cardiovascular risk reduction in primary prevention: A 44-week open label prospective study
Diabetes and Metabolic Syndrome: Clinical Research and Reviews, Vol. 19, Núm. 9
-
Epigenetic regulation of electromechanical continuity might determine phenotypic heterogeneity in SCN5A mutation carriers in Brugada syndrome
Scientific Reports, Vol. 15, Núm. 1
-
Plasma small extracellular vesicles: Markers and mediators of atrial scar, in patients with atrial fibrillation
Heart Rhythm, Vol. 22, Núm. 12, pp. 3257-3267
-
Prevalence and relevance of H558R in the efficacy and toxicity of flecainide in patients with atrial fibrillation: a cohort study
Heart, Vol. 111, Núm. 4, pp. 159-165
-
Relevance of CYP2D6 in the Efficacy and Toxicity of Flecainide in Patients With Atrial Fibrillation:. Cohort Study
Journal of Cardiovascular Pharmacology, Vol. 86, Núm. 4, pp. 384-390
-
Simplified 3-ganglionated plexus ablation for the treatment of recurrent vasovagal syncope and functional bradyarrhythmia
Heart Rhythm
-
Single-chamber pacemakers: with or without leads? Cost-effectiveness and cost-utility analyses
Annals of Medicine, Vol. 57, Núm. 1
2024
-
Cost–Utility Analysis of PCSK9 Inhibitors and Quality of Life: A Two-Year Multicenter Non-Randomized Study
Diseases, Vol. 12, Núm. 10
-
Effect of age on clinical impact and mid-term denervation in patients undergoing cardioneuroablation
Scientific Reports, Vol. 14, Núm. 1
-
Enhanced Levels of Adiposity, Stretch and Fibrosis Markers in Patients with Coexistent Heart Failure and Atrial Fibrillation
Journal of Cardiovascular Translational Research, Vol. 17, Núm. 1, pp. 13-23
-
Enhancing patient outcomes: Integrating electronic cardiology consultation in primary care for cancer patients
European Journal of Clinical Investigation, Vol. 54, Núm. 8
-
Impact of a clinician-to-clinician electronic consultation in heart failure patients with previous hospital admissions
European Heart Journal - Digital Health, Vol. 5, Núm. 1, pp. 9-20
-
Pseudotransposition of the great leads
PACE - Pacing and Clinical Electrophysiology, Vol. 47, Núm. 2, pp. 233-235
-
Transforming Cardiotoxicity Detection in Cancer Therapies: The Promise of MicroRNAs as Precision Biomarkers
International Journal of Molecular Sciences, Vol. 25, Núm. 22
2023
-
Atrial fibrillation ablation in patients with arrhythmia-induced cardiomyopathy: a prospective multicentre study
ESC Heart Failure, Vol. 10, Núm. 5, pp. 3055-3066
-
Characterization of Atrial Substrate to Predict the Success of Pulmonary Vein Isolation: The Prospective, Multicenter MASH-AF II (Multipolar Atrial Substrate High Density Mapping in Atrial Fibrillation) Study
Journal of the American Heart Association, Vol. 12, Núm. 1, pp. e027795